# US 2024/0002874 A1 · Increasing photosynthetic capacity in plants

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002874 A1
- Document ID: US20240002874A1
- Status: Published application
- Kind: A1
- Application number: 18/257,836
- Filed: 2021-11-18
- Published: 2024-01-04
- Earliest claimed: 2020-12-18
- Assignees: University of Essex Enterprises Limited
- Applicants: University of Essex Enterprises Limited
- Inventors: Philip M Mullineaux; Ellie J. Stallard
- Web page: https://patentgrep.com/patent/US20240002874A1

## CPC

- C07K 14/415: from plants
- C12N 15/8269: {Photosynthesis}
- A01H 3/02: by controlling duration, wavelength, intensity, or periodicity of illumination
- C12N 15/82: for plant cells {, e.g. plant artificial chromosomes (PACs)}
- C12Q 1/6895: for plants, fungi or algae
- C12Q 2600/156: Polymorphic or mutational markers
- Y02A 40/146: Genetically Modified [GMO] plants, e.g. transgenic plants
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A01H: NEW PLANTS OR {NON-TRANSGENIC} PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The invention relates to methods of increasing photosynthetic capacity in plants by modulating the cryptochrome 1 (CRY1)-directed signalling pathway. In certain embodiments, the invention relates to removing constraints on maximal photosynthetic capacity by reducing or abolishing SPA gene expression and/or activity. The invention further relates to plants having increased photosynthetic capacity, identifying plants with increased photosynthetic capacity and methods of producing food or feed products.

## Claims

### Claim 1

A method of increasing photosynthetic capacity in a plant, the method comprising modulating Cryptochrome 1 (CRY1)-directed signalling in the plant.

### Claim 2 (depends on 1)

The method of claim 1, wherein modulating CRY1-directed signalling comprises reducing or abolishing the expression of at least one nucleic acid sequence encoding a Suppressor of PhyA-105 (SPA) polypeptide and/or reducing or abolishing the activity of a SPA polypeptide in the plant, wherein optionally comprising reducing or abolishing the expression and/or activity of one, two or three SPA polypeptides, wherein the nucleic acid sequences are selected from SPA1, SPA2, SPA3 and/or SPA4.

### Claim 3

(canceled)

### Claim 4 (depends on 1)

The method of claim 1, wherein modulating CRY1-directed signalling comprises:
(a) reducing or abolishing the expression of at least one nucleic acid sequence encoding a B-Box Domain containing protein 32 (BBX32) polypeptide and/or reducing or abolishing the activity of a BBX32 polypeptide in the plant; and/or
(b) reducing or abolishing the expression of at least one nucleic acid sequence encoding a Constitutively Photomorphogenic (COP) polypeptide and/or reducing or abolishing the activity of a COP polypeptide in the plant; and/or
(c) increasing the expression of at least one nucleic acid sequence encoding a Cryptochrome 1 (CRY1), Long Hypocotyl 5 (HY5), Phytochrome Interacting Factor (PIF) and/or Phytochrome B (PHYB) polypeptide; and/or
(d) increasing the activity of a CRY, HY5, PIF and/or PHYB polypeptide in the plant.

### Claim 5

(canceled)

### Claim 6

(canceled)

### Claim 7 (depends on 1)

The method of claim 1, wherein shoot growth of the plant is significantly the same or improved as compared to a control or wild-type plant, wherein optionally the PSII operating efficiency (Fq′/Fm′) of the plant is increased by about 40% or more as compared to a control or wild-type plant, wherein the actinic photosynthetically active photon flux density (PFFD) is about 800 μmol m−2 s−1.

### Claim 8

(canceled)

### Claim 9 (depends on 1)

The method of claim 1, wherein the method comprises introducing at least one mutation into the nucleic acid sequence encoding 5 the SPA, BBX32 and/or COP polypeptide(s), wherein optionally the mutation is a loss of function mutation, further optionally an insertion, deletion or substitution.

### Claim 10

(canceled)

### Claim 11 (depends on 9)

The method of claim 9, wherein:
(a) the mutation is introduced by insertional mutagenesis, optionally transposon mutagenesis;
(b) the mutation is identified by a Targeted Induced Local Lesions in Genomics (TILLING) method; or
(c) the mutation is introduced by genome-editing, optionally CRISPR/Cas9.

### Claim 12 (depends on 1)

The method of claim 1, wherein a transgenic construct is introduced into the plant, wherein:
(a) the transgenic construct is capable of reducing or abolishing the expression of the nucleic acid encoding a SPA, BBX32 and/or COP polypeptide;
(b) the transgenic construct is capable of reducing or abolishing the activity of a SPA, BBX32 and/or COP polypeptide;
(c) the transgenic construct is capable of increasing the expression of the CRY1, HY5, PIF and/or PHYB polypeptide; or
(d) the transgenic construct is capable of increasing the activity of the CRY1, HY5, PIF and/or PHYB polypeptide.

### Claim 13 (depends on 1)

The method of claim 1, wherein the plant is a crop plant, wherein optionally the crop plant is grown under controlled light conditions, wherein further optionally the light conditions are optimised depending on the photosynthetic capacity of the plant.

### Claim 14

(canceled)

### Claim 15

(canceled)

### Claim 16 (depends on 1)

A plant, plant part or seed obtainable by the method of claim 1.

### Claim 17

A plant having modulated CRY-directed signalling, wherein the PSII operating efficiency (Fq′/Fm′) in the plant is increased by about 40% or more as compared to a control or wild-type plant, wherein the PFFD is about 800 μmol m-2 s-1.

### Claim 18 (depends on 17)

The plant of claim 17, wherein the plant has reduced or abolished expression of at least one nucleic acid encoding a SPA, BBX32 and/or COP polypeptide and/or reduced or abolished activity of a SPA, BBX32 and/or COP polypeptide as compared to a control or wildtype plant, wherein optionally the plant has increased expression of at least one nucleic acid sequence encoding a CRY, HY5, PIF and/or PHYB polypeptide and/or increased activity of a CRY, HY5, PIF and/or PHYB polypeptide as compared to a control or wild-type plant.

### Claim 19

(canceled)

### Claim 20 (depends on 17)

The plant of claim 17, wherein the plant is a crop plant, wherein optionally the plant comprises one or more mutations in at least one nucleic acid sequence encoding a SPA, BBX32 and/or COP polypeptide, wherein further optionally:
(a) the mutation is introduced by insertional mutagenesis, optionally transposon mutagenesis;
(b) the mutation is identified by a TILLING method; or
(c) the mutation is introduced by genome-editing, optionally CRISPR/Cas9.

### Claim 21

(canceled)

### Claim 22

(canceled)

### Claim 23 (depends on 17)

The plant of claim 17, wherein the plant comprises a transgenic construct, wherein:
(a) the transgenic construct is capable of reducing or abolishing the expression of the nucleic acid encoding a SPA, BBX32 and/or COP polypeptide;
(b) the transgenic construct is capable of reducing or abolishing the activity of the SPA, BBX32 and/or COP polypeptide;
(c) the transgenic construct is capable of increasing the expression of the CRY1, HY5, PIF and/or PHYB polypeptide; or
(d) the transgenic construct is capable of increasing the activity of the CRY, HY5, PIF and/or PHYB polypeptide.

### Claim 24

A method of identifying one or more alleles associated with increased photosynthetic capacity in one or more plants, the method comprising:
(a) detecting in the plant(s) one or more polymorphism(s) in a nucleic acid sequence encoding a SPA, BBX32, COP, CRY, HY5, PIF and/or PHYB polypeptide, wherein the one or more polymorphism(s) are 5 associated with increased photosynthetic capacity;
(b) identifying one or more allele(s) at the one or more polymorphism(s) that are associated with increased photosynthetic capacity.

### Claim 25 (depends on 24)

The method of claim 24, further comprising introgressing the nucleic acid sequence comprising the one or more polymorphism(s) into a plant having increased photosynthetic capacity, wherein optionally the plant is a crop plant.

### Claim 26

(canceled)

### Claim 27 (depends on 1)

A method of producing a food or feed product in a plant grown under controlled light conditions, the method comprising:
(a) obtaining a plant having increased photosynthetic capacity according to the method of claim 1;
(b) isolating a plant part or seed from the plant; and
(c) producing a food or feed product from the plant part or seed.

### Claim 28

A method of quantifying photosynthetic capacity in one or more plants having modulated CRY-directed signalling, wherein the method comprises:
(a) subjecting the plant to high light (HL) conditions;
(b) subjecting the plant to low light (LL) conditions;
(c) subjecting the plants to increasing actinic PPFD; and
(d) quantifying PSII operating efficiency, linear electron flux and/or quantum yield of CO2 assimilation in the one or more plants.

### Claim 29 (depends on 28)

The method of claim 28, wherein the plant has reduced or abolished expression of at least one nucleic acid sequence encoding a SPA, BBX32 and/or COP polypeptide and/or reduced or abolished activity of a SPA, BBX32 and/or COP polypeptide as compared to a control or wild-type plant, wherein optionally the plant has increased expression of at least one nucleic acid sequence encoding a CRY, HY5, PIF and/or PHYB polypeptide, and/or increased activity of a CRY, HY5, PIF and/or PHYB polypeptide as compared to a control or wild-type plant.

### Claim 30

(canceled)

### Claim 31 (depends on 28)

The method of claim 28, wherein:
(a) the HL conditions comprise a PFFD of about 1100 μmol m-2 s-2 optionally for about 4 hours;
hours;
(b) the LL conditions comprise a PFFD of about 100 μmol m-2 s-2 optionally for about 0.5 hours;
(c) the increasing actinic PPFD comprises between about 200 μmol m-2 s-2 to about 1400 μmol m-2 s-2 optionally in about 200 μmol m-2 s-2 steps for about 5 minutes per step; and/or
(d) chlorophyll fluorescence (CF) measurements are obtained to quantify PSII operating efficiency, linear electron flux and/or quantum yield of CO2 assimilation in the one or more plants, optionally between 1 to 5 days, wherein optionally if the PRI operating efficiency (Fq′/Fm′) is about 40% or more wherein the actinic PFFD is about 800 μmol m-2 s-1, the plant is determined to have increased photosynthetic capacity as compared to a control or wild type plant.

### Claim 32

(canceled)

### Claim 33 (depends on 16)

Use of a plant according to claim 16 for producing a food or feed product, wherein optionally the food or feed product is a non-propagation material such as flour or oil.

### Claim 34

(canceled)
